Physician profile
Robert J Lagman
NPI 1790720514
$8,455.13
in general payments reported to CMS, 2019-2025
38 companies · $1,231 in 2025
The $1,231 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $780 · 2020: $605 · 2021: $1,022 · 2022: $1,524 · 2023: $2,110 · 2024: $1,183 · 2025: $1,231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,969 · Travel and Lodging: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,969.07 |
| Travel and Lodging | $555.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $2,205.07 | 2019-2025 | Puraply, Affinity, Puraply Wound Matrix |
| Stryker Corporation | $1,324.77 | 2019-2025 | Axsos, Variax, Augment Injectable |
| Paratek Pharmaceuticals, INC. | $1,046.79 | 2019-2025 | Nuzyra |
| Horizon Therapeutics Plc | $919.96 | 2019-2023 | Krystexxa |
| Amgen INC. | $437.16 | 2024-2025 | Krystexxa |
| Convatec INC. | $316.57 | 2023-2025 | |
| Smith+Nephew, INC. | $283.07 | 2019-2025 | Collagenase Santyl, Regranex, Q-Fix |
| Journey Medical Corporation | $228.04 | 2019-2021 | |
| Ibsa Pharma INC. | $185.10 | 2023-2025 | Licart, Tirosint, Tirosint |
| Abbvie INC. | $153.43 | 2021-2025 | |
| Treace Medical Concepts, INC. | $143.55 | 2025 | |
| Depuy Synthes Sales INC. | $143.22 | 2024-2025 | Motoband |
| Medtronic, INC. | $135.36 | 2024 | Hawkone |
| Kowa Pharmaceuticals America, INC. | $126.42 | 2022-2023 | Seglentis |
| Musculoskeletal Transplant Foundation INC. | $91.76 | 2020 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Lagman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.